G. Steger

Breast cancer chemoprevention - a vision not yet realized.

M. Gnant, P. Dubsky, R. Jakesz, 2009, European journal of cancer care.

TP 53 Mutation and p 53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients 1

M. Gnant, R. Jakesz, M. Mittlböck, 2000 .

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

R. Greil, W. Eiermann, M. Gnant, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.

M. Gnant, R. Jakesz, R. Mader, 2000, Cancer biotherapy & radiopharmaceuticals.

Cutaneous reactions to GM-CSF in inflammatory breast cancer.

M. Gnant, W. Aberer, R. Jakesz, 1992, The New England journal of medicine.

Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results.

M. Schemper, M. Gnant, R. Jakesz, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study.

M. Gnant, R. Jakesz, A. Reiner, 1992, European journal of cancer.

GM‐CSF in the treatment of a patient with severe methotrexate intoxication

C. Marosi, M. Gnant, R. Jakesz, 1993, Journal of Internal Medicine.

Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?

M. Gnant, R. Steininger, S. Rasoul-rockenschaub, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[Primary (preoperative, neoadjuvant) chemotherapy of colon cancer--a therapeutic alternative?].

R. Jakesz, G. Steger, 1994, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

M. Gnant, R. Jakesz, G. Steger, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Current status of adjuvant therapy in patients with colorectal cancer: report and commentary on the Consensus Conference, 16-18 April 1990, National Cancer Institute, Bethesda, Maryland].

R. Jakesz, G. Steger, 1991, Wiener Klinische Wochenschrift.